Michael J. Jelinek

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison et al. · Journal of Thoracic Oncology · 2021 · 141 citations

Medicine, Oncology, Radiation Oncology +11

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer

Ari J. Rosenberg, Aditya Juloori, Michael J. Jelinek et al. · JAMA Oncology · 2025 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Management of Early Head and Neck Cancer in Elderly Patients

Michael J. Jelinek, Adam Howard, Daniel J. Haraf et al. · Journal of Oncology Practice · 2018 · 22 citations · Full text

Medicine, Geriatric Medicine, Oncology +13

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

Michael J. Jelinek, Nathan R. Foster, Alexander Zoroufy et al. · Oral Oncology · 2021 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Jérôme Fayette, Lisa Licitra, Kevin J. Harrington et al. · Clinical Cancer Research · 2025 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16